Ping An Biomedical Co., Ltd. (PASW)

Ping An Biomedical Financials Overview

Financials in millions CNY. Fiscal year is October - September.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Revenue Revenue Growth	25.51	34.15	87.62	82.56	114.55	99.52
Revenue Growth	-25.29%	-61.03%	6.13%	-27.92%	15.10%	79.43%
Gross Profit Gross Profit Growth	2.37	0.95	5.42	4.24	14.14	14.27
Operating Income Operating Income Growth	-10.55	-14.7	-0	0.61	10.82	8.27
Net Income Net Income Growth	-3.77	-12.83	-1.28	-0.99	7.23	5.21
Earnings Per Share EPS Growth	-0.11	-0.69	-0.07	-0.06	0.40	0.29
EPS Growth	-	-	-	-	38.61%	170.96%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Sales of Yarns Sales of Yarns Growth	24.49	32.42	83.27	77.04	108.99	89.18
Sales of Finished Garments Sales of Finished Garments Growth	1.02	1.73	4.35	5.52	5.56	10.34
Total Total Growth	25.51	34.15	87.62	82.56	114.55	99.52

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Investments Cash & Investments Growth	6.84	1.17	0.13	0.59	1.23	0.11
Total Debt Total Debt Growth	10.27	10.47	10.81	42.96	56.16	61.2
Net Cash (Debt) Net Cash Growth	-3.43	-9.3	-10.68	-42.36	-54.93	-61.09
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-0.10	-0.50	-0.59	-2.35	-3.05	-3.39

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Operating Cash Flow Operating Cash Flow Growth	-5.54	-6.43	14.63	-6.08	21.09	-31.37
Capital Expenditures CapEx Growth	-	-	-	-	-0.02	-0.03
Free Cash Flow Free Cash Flow Growth	-5.54	-6.43	14.63	-6.08	21.06	-31.4
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Gross Margin	9.27%	2.78%	6.18%	5.14%	12.35%	14.34%
Operating Margin	-41.34%	-43.05%	-0.00%	0.74%	9.44%	8.31%
Pretax Margin	-18.28%	-43.00%	-0.78%	0.05%	8.40%	7.86%
Profit Margin	-14.78%	-37.57%	-1.47%	-1.20%	6.31%	5.24%
FCF Margin	-21.73%	-18.82%	16.70%	-7.37%	18.39%	-31.55%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 9, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
PS Ratio	4.03	5.30	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 11, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 8, 2026

Data Sources Report a data error